39 results
8-K
EX-99.1
ANEB
Anebulo Pharmaceuticals Inc
13 Feb 24
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024
4:15pm
stockholders’ equity
Condensed Statements of Operations
Three Months Ended December 31,
Research and development
General and administrative
Total operating
8-K
EX-99.1
ANEB
Anebulo Pharmaceuticals Inc
14 Nov 23
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024
4:19pm
Total stockholders’ equity
Condensed Statements of Operations
Three Months Ended September 30,
Research and development
General and administrative
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
, research or development of Company (regardless of when or where the Work Product is prepared or whose equipment or other resources is used in preparing
8-K
EX-99.1
qmpnq181 2oqu26ya9
20 Sep 23
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023
4:15pm
8-K
EX-99.1
ht5l66j hpvzamh81
11 May 23
Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates
8:15am
8-K
EX-99.1
08xw6y8d06ospomwv bf
10 Nov 22
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
8:15am
DEFR14A
yfbubz
25 Oct 22
Revised proxy
5:27pm
8-K
EX-99.1
517dk htozzmg9bd
9 Sep 22
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022
8:00am
8-K
EX-99.1
njoms4z
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm
8-K
EX-10.1
75g48zi1cmv
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm
8-K
EX-99.1
0aw19g1o xj6dfrqci3
11 May 22
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates
9:00am